| |
| |
|
| Insider
Information: |
Moat Ross |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
16,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$318,684 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,276 |
|
|
| Total
Value |
$318,684 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
16,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$24,219 |
D/D |
(1,353) |
16,276 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,477 |
17,629 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$17,336 |
D/D |
(880) |
15,152 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,612 |
16,032 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$9,644 |
D/D |
(543) |
14,420 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
994 |
14,963 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,477 |
15,322 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$24,029 |
D/D |
(1,353) |
13,969 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-07-15 |
4 |
A |
$12.35 |
$3,606 |
D/D |
292 |
12,845 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$14,491 |
D/D |
(1,353) |
12,553 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,477 |
13,906 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$12,977 |
D/D |
(1,167) |
11,429 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,137 |
12,596 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$6,223 |
D/D |
(543) |
10,459 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
994 |
11,002 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2023-01-15 |
4 |
A |
$9.56 |
$17,629 |
D/D |
1,844 |
10,008 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-09-02 |
4 |
D |
$11.44 |
$6,441 |
D/D |
(563) |
8,164 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
995 |
8,727 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-07-15 |
4 |
A |
$9.56 |
$3,442 |
D/D |
360 |
7,732 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,270 |
8,612 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF COMMERCIAL OFFICER |
• – – |
2022-03-21 |
4 |
D |
$10.98 |
$13,615 |
D/D |
(1,240) |
7,372 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Commercial Officer |
• – – |
2022-03-16 |
4 |
D |
$10.13 |
$5,511 |
D/D |
(544) |
6,342 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Commercial Officer |
• – – |
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
995 |
6,886 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Commercial Officer |
• – – |
2022-01-15 |
4 |
A |
$9.63 |
$14,888 |
D/D |
1,546 |
5,891 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Commercial Officer |
• – – |
2021-07-15 |
4 |
A |
$11.49 |
$11,065 |
D/D |
963 |
4,345 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
